据统计,大约 50% 的 ICU 患者会遭遇 AKI。面对这一困境,连续肾脏替代治疗(CRRT)成为了重要的治疗手段,然而,即便有了 CRRT,患者的发病率和死亡率依旧居高不下。传统的死亡率预测模型,如急性生理学与慢性健康评估 II(APACHE II)、简化急性生理学评分 II ...
在连续肾脏替代治疗(CRRT)过程中,区域枸橼酸抗凝相较于全身肝素抗凝,在延长滤器使用寿命和降低出血风险方面具有优势。然而,由于潜在的不良事件以及缺乏标准化的方案,在资源有限的重症监护病房(ICU)实施区域枸橼酸抗凝颇具挑战。本研究旨在评估 ...
Up to 3 unexposed patients were selected by matching ... IL), since 1998. ICU admission time to CRRT start, median (IQR) days 1.3 (0.4 to 2.8) 1.7 (0.8 to 3.3) 0.05 b Pre-ICU hospital LOS, median ...
seems to be the best predictor of successful discontinuation of CRRT, according to a study published in Critical Care Medicine. Corresponding author Rinaldo Bellomo states that such information ...
We cross-matched patients who received calcium with ... of ICU admission and pre-inception ICU length of stay. ICU admission time to CRRT start, median (IQR) days 1.3 (0.4 to 2.8) 1.7 (0.8 to ...
Q4 2024 Earnings Call Transcript March 31, 2025 Talphera, Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.21. Operator: Welcome to the Talphera Fourth Quarter and Full ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果